• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Stifel Financial Corporation filed SEC Form 8-K: Results of Operations and Financial Condition

    5/22/25 4:16:22 PM ET
    $SF
    Investment Bankers/Brokers/Service
    Finance
    Get the next $SF alert in real time by email
    8-K
    STIFEL FINANCIAL CORP false 0000720672 0000720672 2025-05-22 2025-05-22 0000720672 us-gaap:CommonStockMember 2025-05-22 2025-05-22 0000720672 us-gaap:SeriesBPreferredStockMember 2025-05-22 2025-05-22 0000720672 us-gaap:SeriesCPreferredStockMember 2025-05-22 2025-05-22 0000720672 us-gaap:SeriesDPreferredStockMember 2025-05-22 2025-05-22 0000720672 sfb:M5.20SeniorNotesDue2047Member 2025-05-22 2025-05-22
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of the

    Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 22, 2025

     

     

    STIFEL FINANCIAL CORP.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-09305   43-1273600
    (State of incorporation)   (Commission File Number)  

    (IRS Employer

    Identification No.)

    501 N. Broadway, St. Louis, Missouri 63102-2188

    (Address of principal executive offices and zip code)

    (314) 342-2000

    (Registrant’s telephone number, including area code)

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class

     

    Trading

    Symbol(s)

     

    Name of Each Exchange on Which

    Registered

    Common Stock, $0.15 par value per share   SF   New York Stock Exchange
    Depository Shares, each representing 1/1,000th interest in a share of 6.25% Non-Cumulative Preferred Stock, Series B   SF-PB   New York Stock Exchange
    Depository Shares, each representing 1/1,000th interest in a share of 6.125% Non-Cumulative Preferred Stock, Series C   SF-PC   New York Stock Exchange
    Depository Shares, each representing 1/1,000th interest in a share of 4.50% Non-Cumulative Preferred Stock, Series D   SF-PD   New York Stock Exchange
    5.20% Senior Notes due 2047   SFB   New York Stock Exchange

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 7.01 Regulation FD Disclosure.

    On May 22, 2025, Stifel Financial Corp. (the “Company”) issued a press release to disclose selected operating results for April 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Report on Form 8-K and is incorporated by reference.

    The exhibit is being furnished pursuant to Item 2.02, and the information contained therein shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

    Item 9.01 Financial Statements and Exhibits.

    (d)  Exhibits.

     

    Exhibit
    Number
      

    Description

    99.1    Press release dated May 22, 2025.
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    2


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

     

         

    STIFEL FINANCIAL CORP.

    (Registrant)

    Date: May 22, 2025     By:  

     /s/ James M. Marischen

        Name:    James M. Marischen
        Title:    Chief Financial Officer

     

    3

    Get the next $SF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SF

    DatePrice TargetRatingAnalyst
    4/24/2025$108.00Peer Perform → Outperform
    Wolfe Research
    12/10/2024$120.00Neutral
    Analyst
    9/12/2024$101.00Overweight
    Wells Fargo
    7/22/2024Outperform → Peer Perform
    Wolfe Research
    7/8/2024$94.00 → $89.00Buy → Hold
    TD Cowen
    1/4/2024$83.00Outperform
    TD Cowen
    11/22/2022$66.00Neutral
    UBS
    10/12/2022$60.00Neutral
    Citigroup
    More analyst ratings